Following my cortisol blood test, I've spoken with several doctors to better understand my "high cortisol" results and answer ...
GeneDx says it has an 80% share of the U.S. exome sequencing market. Newborn screening represents a $10 billion-per-year ...
Quest Diagnostics and Elevance Health are broadening their partnership into four more states with the goal of making it ...
On Friday, Quest Diagnostics Inc (DGX) stock saw a modest uptick, ending the day at $160.44 which represents a slight increase of $3.60 or 2.30% from the prior close of $156.84. The stock opened at ...
By combining ExamOne’s expertise in records retrieval with DigitalOwl’s advanced AI-driven analysis capabilities, clients can expect an enhanced overall workflow, reduced processing times, and ...
Apollon Wealth Management LLC lowered its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 10.4% ...
Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
StockNews.com lowered shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a hold rating in a report ...
Quest Diagnostics Inc.’s DGX robust Advanced Diagnostics offering is poised to drive its growth in the upcoming quarters. Strength in the company’s core business is highly encouraging. Additionally, a ...
The test will measure levels of the 14-3-3eta protein, which is used in the diagnosis and management of inflammatory diseases including rheumatoid arthritis.